BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 35576971)

  • 1. OCA-T1 and OCA-T2 are coactivators of POU2F3 in the tuft cell lineage.
    Wu XS; He XY; Ipsaro JJ; Huang YH; Preall JB; Ng D; Shue YT; Sage J; Egeblad M; Joshua-Tor L; Vakoc CR
    Nature; 2022 Jul; 607(7917):169-175. PubMed ID: 35576971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. POU2F3 is a master regulator of a tuft cell-like variant of small cell lung cancer.
    Huang YH; Klingbeil O; He XY; Wu XS; Arun G; Lu B; Somerville TDD; Milazzo JP; Wilkinson JE; Demerdash OE; Spector DL; Egeblad M; Shi J; Vakoc CR
    Genes Dev; 2018 Jul; 32(13-14):915-928. PubMed ID: 29945888
    [TBL] [Abstract][Full Text] [Related]  

  • 3. POU2AF2/C11orf53 functions as a coactivator of POU2F3 by maintaining chromatin accessibility and enhancer activity.
    Szczepanski AP; Tsuboyama N; Watanabe J; Hashizume R; Zhao Z; Wang L
    Sci Adv; 2022 Oct; 8(40):eabq2403. PubMed ID: 36197978
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular Classification of Extrapulmonary Neuroendocrine Carcinomas With Emphasis on POU2F3-positive Tuft Cell Carcinoma.
    Koh J; Kim H; Moon KC; Lee C; Lee K; Ryu HS; Jung KC; Jeon YK
    Am J Surg Pathol; 2023 Feb; 47(2):183-193. PubMed ID: 36253891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Made to order tuft cells by an OCA-T1 isoform switch.
    Wu XS; Vakoc CR
    Sci Immunol; 2023 May; 8(83):eadh3123. PubMed ID: 37172101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting the mSWI/SNF Complex in POU2F-POU2AF Transcription Factor-Driven Malignancies.
    He T; Xiao L; Qiao Y; Klingbeil O; Young E; Wu XS; Mannan R; Mahapatra S; Eyunni S; Tien JC; Wang X; Zheng Y; Kim N; Zheng H; Hou S; Su F; Miner SJ; Mehra R; Cao X; Sekhar AC; Samajdar S; Ramachandra M; Parolia A; Vakoc CR; Chinnaiyan AM
    bioRxiv; 2024 Jan; ():. PubMed ID: 38328238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An exploratory study for tuft cells in the breast and their relevance in triple-negative breast cancer: the possible relationship of SOX9.
    Yamada Y; Simon R; Iwane K; Nakanishi Y; Takeuchi Y; Yoshizawa A; Takada M; Toi M; Haga H; Marx A; Sauter G
    BMC Cancer; 2023 May; 23(1):438. PubMed ID: 37179317
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genetic mapping reveals
    Nadjsombati MS; Niepoth N; Webeck LM; Kennedy EA; Jones DL; Billipp TE; Baldridge MT; Bendesky A; von Moltke J
    Sci Immunol; 2023 May; 8(83):eade5019. PubMed ID: 37172102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Tuft Cell-Like Signature Is Highly Prevalent in Thymic Squamous Cell Carcinoma and Delineates New Molecular Subsets Among the Major Lung Cancer Histotypes.
    Yamada Y; Simon-Keller K; Belharazem-Vitacolonnna D; Bohnenberger H; Kriegsmann M; Kriegsmann K; Hamilton G; Graeter T; Preissler G; Ott G; Roessner ED; Dahmen I; Thomas RK; Ströbel P; Marx A
    J Thorac Oncol; 2021 Jun; 16(6):1003-1016. PubMed ID: 33609752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intestinal epithelial tuft cells initiate type 2 mucosal immunity to helminth parasites.
    Gerbe F; Sidot E; Smyth DJ; Ohmoto M; Matsumoto I; Dardalhon V; Cesses P; Garnier L; Pouzolles M; Brulin B; Bruschi M; Harcus Y; Zimmermann VS; Taylor N; Maizels RM; Jay P
    Nature; 2016 Jan; 529(7585):226-30. PubMed ID: 26762460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Skn-1a/Pou2f3 functions as a master regulator to generate Trpm5-expressing chemosensory cells in mice.
    Yamashita J; Ohmoto M; Yamaguchi T; Matsumoto I; Hirota J
    PLoS One; 2017; 12(12):e0189340. PubMed ID: 29216297
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lineage tracing and targeting of IL17RB
    Goto N; Fukuda A; Yamaga Y; Yoshikawa T; Maruno T; Maekawa H; Inamoto S; Kawada K; Sakai Y; Miyoshi H; Taketo MM; Chiba T; Seno H
    Proc Natl Acad Sci U S A; 2019 Jun; 116(26):12996-13005. PubMed ID: 31182574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IκBζ is a dual-use coactivator of NF-κB and POU transcription factors.
    Alpsoy A; Wu XS; Pal S; Klingbeil O; Kumar P; El Demerdash O; Nalbant B; Vakoc CR
    Mol Cell; 2024 Mar; 84(6):1149-1157.e7. PubMed ID: 38309274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. POU2F3 beyond thymic carcinomas: expression across the spectrum of thymomas hints to medullary differentiation in type A thymoma.
    Yamada Y; Sugimoto A; Hoki M; Yoshizawa A; Hamaji M; Date H; Haga H; Marx A
    Virchows Arch; 2022 Apr; 480(4):843-851. PubMed ID: 34988657
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequence-specific DNA binding of the B-cell-specific coactivator OCA-B.
    Cepek KL; Chasman DI; Sharp PA
    Genes Dev; 1996 Aug; 10(16):2079-88. PubMed ID: 8769650
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tuft Cells-Systemically Dispersed Sensory Epithelia Integrating Immune and Neural Circuitry.
    O'Leary CE; Schneider C; Locksley RM
    Annu Rev Immunol; 2019 Apr; 37():47-72. PubMed ID: 30379593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. POU2F3 in SCLC: Clinicopathologic and Genomic Analysis With a Focus on Its Diagnostic Utility in Neuroendocrine-Low SCLC.
    Baine MK; Febres-Aldana CA; Chang JC; Jungbluth AA; Sethi S; Antonescu CR; Travis WD; Hsieh MS; Roh MS; Homer RJ; Ladanyi M; Egger JV; Lai WV; Rudin CM; Rekhtman N
    J Thorac Oncol; 2022 Sep; 17(9):1109-1121. PubMed ID: 35760287
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary cancers across different histotypes share hybrid tuft cell/ionocyte-like molecular features and potentially druggable vulnerabilities.
    Yamada Y; Belharazem-Vitacolonnna D; Bohnenberger H; Weiß C; Matsui N; Kriegsmann M; Kriegsmann K; Sinn P; Simon-Keller K; Hamilton G; Graeter T; Preissler G; Ott G; Schölch S; Nakajima N; Yoshizawa A; Haga H; Date H; Thomas RK; Petrini I; Giaccone G; Ströbel P; Marx A
    Cell Death Dis; 2022 Nov; 13(11):979. PubMed ID: 36402755
    [TBL] [Abstract][Full Text] [Related]  

  • 19. POU2F3-expressing intraepithelial small-cell carcinoma with mixed small-cell carcinoma and conventional-type urothelial carcinoma of the urinary bladder.
    Galea LA; Batrouney A; Flynn M; Christie M
    Virchows Arch; 2024 Apr; ():. PubMed ID: 38600174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. OCA-B is a functional analog of VP16 but targets a separate surface of the Oct-1 POU domain.
    Babb R; Cleary MA; Herr W
    Mol Cell Biol; 1997 Dec; 17(12):7295-305. PubMed ID: 9372961
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.